EP1578419A4
Immunostimulatory combinations
13 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13
Every citation, both waysCites: the store holds 0 of 1
| Reference | Relation | Cited during |
|---|---|---|
| O'HAGAN D T ET AL: "Recent developments in adjuvants for vaccines against infectious diseases", BIOMOLECULAR ENGINEERING, ELSEVIER, NEW YORK, NY, US, vol. 18, no. 3, 15 October 2001 (2001-10-15), pages 69 - 85, XP004305905, ISSN: 1389-0344 | Non-patent | Search report |
| UNDERHILL D M ET AL: "Toll-like receptors: key mediators of microbe detection", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, vol. 14, no. 1, 1 February 2002 (2002-02-01), pages 103 - 110, XP004332741, ISSN: 0952-7915 | Non-patent | Search report |
| OHASHI P S ET AL: "Making and breaking tolerance", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, vol. 14, no. 6, 1 December 2002 (2002-12-01), pages 744 - 759, XP004390314, ISSN: 0952-7915 | Non-patent | Search report |
27 members in 6 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 437398P | United States of America | – | |
| 43739802 | United States of America | P | |
| 43739802 | United States of America | P | |
| 0341796 | United States of America | W | |
| 0341796 | United States of America | W | |
| 437398P | – | – | – |
| US20020437398P | – | – | – |
| US2003041796 | – | – | – |
| WO2003US41796 | – | – | – |
Members27
| Document | Office | Kind | |
|---|---|---|---|
| CA2511538A1 | Canada | A1 | |
| US2004141950A1 | United States of America | A1 | |
| WO2004060319A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003300184A1 | Australia | A1 | |
| WO2004060319A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1578419A2 | European Patent Office (EPO) | A2 | |
| JP2006512391A | Japan | A | |
| US7387271B2 | United States of America | B2 | |
| EP1578419A4This record | European Patent Office (EPO) | A4 | |
| US2009123460A1 | United States of America | A1 | |
| AU2003300184B2 | Australia | B2 | |
| AU2003300184B8 | Australia | B8 | |
| US2011002946A1 | United States of America | A1 | |
| JP2011016811A | Japan | A | |
| JP2011105749A | Japan | A | |
| US7993659B2 | United States of America | B2 | |
| US2011280903A1 | United States of America | A1 | |
| US8329197B2 | United States of America | B2 | |
| EP2572714A1 | European Patent Office (EPO) | A1 | |
| EP2572715A1 | European Patent Office (EPO) | A1 | |
| US2013115228A1 | United States of America | A1 | |
| CA2511538C | Canada | C | |
| JP2014101371A | Japan | A | |
| US9161976B2 | United States of America | B2 | |
| US2016129095A1 | United States of America | A1 | |
| US10105426B2 | United States of America | B2 | |
| US2019083592A1 | United States of America | A1 |
10 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA | STAA | |
| First examination report despatched17Q | 17Q | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Request for extension of the european patent (deleted)DAX | DAX | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 1578419
- Publication, DOCDB
- 1578419
- Publication, EPODOC
- EP1578419
- Application
- 3800433
- Application, DOCDB
- 03800433
- Application, EPODOC
- EP20030800433
Titles3
- German
- IMMUNSTIMULIERENDE KOMBINATIONEN
- English
- IMMUNOSTIMULATORY COMBINATIONS
- French
- COMPLEXES IMMUNOSTIMULANTS
Classification
- CPC, 48
- A61K31/4745
- A61K39/39
- A61K45/06
- A61K2039/55511
- A61K2039/55561
- A61K2039/55572
- A61K38/164
- A61K39/39541
- A61K31/5377
- A61K31/7084
- A61K31/7115
- A61K31/739
- A61K38/08
- A61K38/10
- A61P11/06
- A61P17/00
- A61P17/02
- A61P17/14
- A61P25/00
- A61P27/16
- A61P31/00
- A61P31/04
- A61P31/10
- A61P31/12
- A61P31/16
- A61P31/18
- A61P31/20
- A61P31/22
- A61P33/00
- A61P33/02
- A61P35/00
- A61P35/02
- A61P37/00
- A61P37/02
- A61P37/04
- A61P37/08
- A61P43/00
- A61P7/00
- A61K39/0011
- Y02A50/30
- A61K39/3955
- A61K39/0002
- A61K39/02
- A61K39/12
- A61K2039/505
- A61K2039/55516
- A61K2039/572
- A61K2039/585
- IPC, 13
- A61K31 4745
- A61K38 08
- A61K38 16
- A61K38 17
- A61K39 00
- A61K39 39
- A61K45 06
- C12N5 07
- C12N5 0783
- C12N5 09
- A61K31 435
- C07K14 705
- C07K16 00
Designated states1
- Contracting states, 1
- Türkiye
